Prof. Philip Hawkins, FMedSci
Prof. Philip Hawkins is a Professor of Medicine at University College London and Clinical Director of the NHS National Amyloidosis Centre at The Royal Free. He is a rheumatologist and clinical scientist renowned for his studies on amyloidosis. His seminal work includes development and implementation of serum amyloid P component (SAP) scintigraphy for diagnosis and quantification of systemic amyloidosis.
Philip Hawkins studied medicine at St. George’s Hospital Medical School, London where he qualified with distinction in 1982. After training in general internal medicine at St. George’s, he undertook specialist training in rheumatology at the Royal Postgraduate Medical School, Hammersmith Hospital where he subsequently obtained his PhD for studies on the pathogenesis and diagnosis of amyloidosis during a Medical Research Council Training Fellowship.
Dr. Hawkin’s clinical research programme is focused on diagnosis, pathogenesis, monitoring and treatment of amyloidosis and inherited autoinflammatory diseases with an emphasis on translational, early phase and otherwise novel approaches. He has a particular interest in the development of new imaging methods.
Representative Publications:
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers
High prevalence of intracardiac thrombi in cardiac amyloidosis
Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis
Spinal stenosis in familial transthyretin amyloidosis
